Cargando…
Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation
Phorbol myristate acetate (pma) is a potent mitogen for human peripheral blood lymphocytes (PBL) comparable to phytohemagglutinin (PHA) in potency. Inactivation of PHA-responsive lymphocytes by 5'- bromodeoxyuridine and light treatment left the PMA response intact and nice versa. Experiments se...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1977
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2180613/ https://www.ncbi.nlm.nih.gov/pubmed/299884 |
_version_ | 1782145587393593344 |
---|---|
collection | PubMed |
description | Phorbol myristate acetate (pma) is a potent mitogen for human peripheral blood lymphocytes (PBL) comparable to phytohemagglutinin (PHA) in potency. Inactivation of PHA-responsive lymphocytes by 5'- bromodeoxyuridine and light treatment left the PMA response intact and nice versa. Experiments separating lymphocytes by rosetting with sheep erythrocytes (SRBC) demonstrated that the PMA-responsive lymphocytes segregate with those that have a high affinity for SRBC to a greater than PHA- or concanavalin A (Con A)-responsive cells. These results indicate that a PMA-responsive population in human peripheral blood resides within the T-lymphocyte population and appears to have a high affinity for SRBC and to be distinct from that responding to PHA and Con A. PMA may be useful clinically to assay the size and function of the high affinity or "active" rosette population. |
format | Text |
id | pubmed-2180613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1977 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21806132008-04-17 Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation J Exp Med Articles Phorbol myristate acetate (pma) is a potent mitogen for human peripheral blood lymphocytes (PBL) comparable to phytohemagglutinin (PHA) in potency. Inactivation of PHA-responsive lymphocytes by 5'- bromodeoxyuridine and light treatment left the PMA response intact and nice versa. Experiments separating lymphocytes by rosetting with sheep erythrocytes (SRBC) demonstrated that the PMA-responsive lymphocytes segregate with those that have a high affinity for SRBC to a greater than PHA- or concanavalin A (Con A)-responsive cells. These results indicate that a PMA-responsive population in human peripheral blood resides within the T-lymphocyte population and appears to have a high affinity for SRBC and to be distinct from that responding to PHA and Con A. PMA may be useful clinically to assay the size and function of the high affinity or "active" rosette population. The Rockefeller University Press 1977-02-01 /pmc/articles/PMC2180613/ /pubmed/299884 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation |
title | Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation |
title_full | Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation |
title_fullStr | Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation |
title_full_unstemmed | Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation |
title_short | Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation |
title_sort | phorbol myristate acetate: a mitogen selective for a t-lymphocyte subpopulation |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2180613/ https://www.ncbi.nlm.nih.gov/pubmed/299884 |